# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049067
Filing Date
2024-04-26
Accepted
2024-04-26 16:01:08
Documents
11
Period of Report
2024-06-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | eypt_def_14a_04-26-2024.htm | DEF 14A | 1668078
2 | GRAPHIC | img83600834_0.jpg | GRAPHIC | 31402
3 | GRAPHIC | img83600834_1.jpg | GRAPHIC | 6484
4 | GRAPHIC | img83600834_2.jpg | GRAPHIC | 3687
5 | GRAPHIC | img83600834_3.jpg | GRAPHIC | 31402
6 | GRAPHIC | img83600834_4.jpg | GRAPHIC | 17608
7 | GRAPHIC | img83600834_5.jpg | GRAPHIC | 31402
8 | GRAPHIC | img83600834_6.jpg | GRAPHIC | 234957
9 | GRAPHIC | img83600834_7.jpg | GRAPHIC | 242942
10 | GRAPHIC | img83600834_8.jpg | GRAPHIC | 178870
11 | GRAPHIC | img83600834_9.jpg | GRAPHIC | 139971
| Complete submission text file | 0000950170-24-049067.txt |  | 2933932

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51122 | Film No.: 24883374
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)